| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4929747 | Asian Journal of Psychiatry | 2017 | 5 Pages |
Abstract
Review of available literature on the use of buprenorphine in individuals with treatment resistant depression demonstrated efficacy in the treatment of depressive disorders. Further prospective randomized controlled trials should be undertaken to evaluate the efficacy of buprenorphine as an adjunct for depression refractory to current pharmacotherapies.
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Cornel N. Stanciu, Oliver M. Glass, Thomas M. Penders,